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Cultured hamster trachea epithelial cells were selected as an in vitro model
system to study Bordetella pertussis pathogenesis in the respiratory tract. DNA
synthesis by serum-stimulated tracheal cells, in contrast to other cell types tested,
was inhibited by the supernatant from log-phase B. pertussis broth cultures. A
sensitive microassay with these tracheal cells permitted the development of a
chromatographic purification scheme based on aggregation of the biological
activity under salt-free conditions. The active fraction from this first stage of
purification caused a dose-dependent inhibition of DNA synthesis without a
similar effect on RNA or protein synthesis. Organ cultures of hamster tracheal
rings, when exposed to this partially purified fraction, developed epithelial
cytopathology comparable to that seen during B. pertussis infection. Ciliary
activity slowed and eventually ceased as ciliated cells were extruded from the
ring, leaving an intact but mostly nonciliated epithelium. Further purification of
this biological activity was achieved with preparative-scale high-voltage paper
electrophoresis. Based on ninhydrin staining and the radioactive profile of
material purified from radiolabeled B. pertussis cultures, four fractions were
eluted from the paper by descending chromatography. Only component B caused
a dose-dependent inhibition of cultured tracheal cell DNA synthesis and epithelial
cytopathology in tracheal rings. Combination experiments also demonstrated
enhanced inhibition by component B in the presence of component G (oxidized
glutathione), a copurifying molecule from the growth medium. Amino acid
analysis of component B revealed a composition of glutamic acid (five residues),
alanine (five residues), glycine (two residues), cysteine (two residues), and
diaminopimelic acid (one residue), as well as muramic acid and glucosamine.
Seventy years ago, Mallory and Hornor (18)
histologically characterized whooping cough, or
pertussis, as a noninvasive bacterial coloniza-
tion of ciliated cells in the respiratory epitheli-
um. Although much literature on Bordetella
pertussis has accumulated since that study, re-
markably little is known about the pathogenesis
of the disease. A variety of B. pertussis compo-
nents have been purified and characterized, and
they cover an impressive range of biological
activities. However, none has been demonstrat-
ed to be responsible for the primary lesion of
pertussis-cytopathology in the respiratory
tract.
Collier et al. (3) studied cellular pathogenesis
of pertussis in an in vitro model of mammalian
respiratory epithelium, the hamster trachea in
organ culture. They observed the classical asso-
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ciation of bacteria with ciliated cells, mimicking
in vivo infection, followed by selective destruc-
tion of those colonized cells and their extrusion
from the epithelium. Lost ciliated cells cannot
be replaced in the tracheal organ culture system;
therefore, B. pertussis infection results in an
intact but nonciliated epithelium. In vivo, regen-
erative activity might be expected, but the rate
and efficiency of epithelial repair during pertus-
sis infection are unknown. Since ciliated cells
provide the mechanism for transport and clear-
ance of tracheobronchial mucus, the loss or slow
recovery of ciliary activity could be responsible
for congestion of the airways with accumulating
mucous secretions and multiplying bacteria.
Although tracheal organ culture has proved to
be an excellent model in reflecting morphologi-
cal and ultrastructural cytopathology during B.
pertussis infection (see also references 20 and
21), the system has revealed little concerning the
molecular mechanisms of this distinctive patho-
genesis. One of the limitations of tracheal rings
is the difficulty in quantitatively evaluating cyto-
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pathology in terms of the metabolic activity of
the affected cells. Radiolabeling studies are diffi-
cult to interpret because of the variety of cell
types present in the respiratory epithelium. Fur-
thermore, a single experiment often requires the
rings from many separate animals, a complicat-
ing factor in any quantitative assay. Significant
variations in ring size, cell number, and epitheli-
al integrity can be expected not only among
animals but even among rings of the same ani-
mal.
As an alternative model system, we have
developed a reliable technique to isolate a homo-
geneous proliferating epithelial cell population
from the hamster trachea (7). These cells can be
cultured and manipulated much like any estab-
lished cell line, but they are not transformed and
are therefore a relevant system to study cells of
the normal respiratory tract. Like goblet cells of
the hamster trachea, they synthesize and secrete
a mucus-like glycoprotein (8) and retain this
differentiated function throughout their life-span
in vitro; yet like ciliated cells, they allow attach-
ment and colonization by virulent B. pertussis
(W. E. Goldman and J. B. Baseman, Abstr.
Annu. Meet. Am. Soc. Microbiol. 1979, D53, p.
48); this is a property of other tissue culture cells
as well (13). Since the cultured tracheal cells are
able to proliferate readily in vitro, they also
parallel the regenerative epithelial basal cell
population in vivo (17). Thus, these hamster
trachea epithelial (HTE) cells may function as a
multipotential target for B. pertussis, since the
biological characteristics of this homogeneous
cell culture resemble those of three separate
epithelial cell types in the respiratory tract.
Preliminary experiments indicated not only
that B. pertussis could attach to HTE cells, but
also that the supernatant from broth cultures of
phase I (virulent) organisms could inhibit DNA
synthesis in uninfected cells (W. E. Goldman
and J. B. Baseman, Abstr. Annu. Meet. Am.
Soc. Microbiol. 1980, D71, p. 49). The release of
this molecule in log-phase cultures and its
unique toxicity for HTE cells and tracheal rings
have prompted its designation as the B. pertussis
tracheal cytotoxin (TCT), since it is biochemi-
cally unlike previously characterized B. pertus-
sis components. This paper discusses the purifi-
cation of TCT and its interaction with relevant
target cells in vitro as a model for B. pertussis
pathogenesis in vivo.
MATERIALS AND METHODS
Bacterial cultures. Virulent phase I B. pertussis
BB114 (used in vaccine production) was obtained from
C. R. Manclark, Bureau of Biologics, U.S. Food and
Drug Administration, Bethesda, Md. Bacteria were
stored in aliquots at -70°C until grown on agar plates
made with modified Stainer-Scholte medium (SSM)
(12, 25) and 10% sheep blood (in Alsever solution).
Growth on solid medium continued for 3 days at 37°C
in an atmosphere of 95% air-5% C02(3). Transfer of
bacteria to liquid SSM was most successful and con-
sistent if initial seed cultures were grown with 10%
fetal bovine serum (FBS; GIBCO Laboratories, Grand
Island, N.Y.) in SSM. Bacteria were inoculated into
this serum-containing medium at a concentration of 5
x 108 organisms per ml, based on absorbance at 540
nm (3). After 2 h of incubation at 37°C in an atmo-
sphere of 95% air-5% C02, the cultures were placed in
a 37°C shaker bath for 16 h. Bacteria were removed by
centrifugation at 12,000 x g for 10 min, washed twice
with serum-free medium, and then suspended in fresh
SSM without FBS. Inoculation density and growth
conditions in SSM matched those for the serum-
containing medium of the seed cultures. For experi-
ments with radiolabeled TCT, L-[G-3H]glutamic acid
(Amersham, Arlington Heights, Ill.) was added to
SSM at a concentration of 0.5 ,uCi/ml during the last 30
h of broth culture; glutamic acid serves as the primary
carbon source for B. pertussis in SSM.
Cell and organ cultures. HTE cells were isolated and
cultured from frozen stocks as described previously
(7). HEp-2 human epithelial cells and baby hamster
kidney (BHK) cells were obtained from the American
Type Culture Collection, Rockville, Md. Growth me-
dium was usually nutrient mixture F-12 (GIBCO) with
10% FBS and with 100 U of penicillin per ml and 100
,ug of streptomycin per ml. Tracheal rings were pre-
pared (2) from male Syrian golden hamsters (Engle
Laboratory Animals, Inc., Farmerburg, Ind.) between
6 weeks and 4 months of age. In experiments to
evaluate cytopathology, the rings were cultured in
minimum essential medium (MEM; GIBCO) contain-
ing antibiotics, with FBS added to a final concentra-
tion of 10% after a 4-h preexposure to TCT or buffer
controls. The same effects were observed in experi-
ments in which tracheal rings were cultured in the
absence of FBS.
Microassay for HTE cell inhibition. Nearly confluent
monolayers of HTE cells were washed twice with
phosphate-buffered saline (PBS) and then incubated
for 10 min with 0.02% EDTA in PBS, pH 8.0. Trypsin
was added to a final concentration of 0.05%, and rapid
pipetting of this enzyme solution dissociated the cells
from the plastic surface. Bovine serum albumin was
then added to a final concentration of 0.05%, and the
cell suspension was centrifuged for 5 min at 400 x g.
The pellet was resuspended in MEM plus 2.5% FBS at
a concentration of 25,000 cells per ml, as determined
by hemacytometer counts. Microtiter plates (Falcon
Plastics, Oxnard, Calif.) were seeded with 0.2 ml of
the cell suspension in each well and agitated frequently
for 10 min to avoid irregular distribution of cells. Wells
on the outside rows were generally filled with distilled
water to reduce the evaporation of the medium during
incubation. After 48 h of incubation in this low concen-
tration of serum, medium was removed from each well
by gentle suction and replaced with 0.15 ml of MEM.
Test samples, dissolved in PBS, were then added to
triplicate or quadruplicate wells; controls received
PBS alone. Sample wells were supplemented 4 h later
with FBS at a final concentration of 10%. At 8 h after
serum stimulation, [methyl-3H]thymidine (Schwarz/
Mann, Orangeburg, N.Y.; 50 to 60 Ci/mmol), was
added at 2.5 ,uCi/ml of medium. The total volume in
each well was not greater than 0.2 ml after all addi-
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tions. At 26 h after stimulation, samples were harvest-
ed with cotton-tipped applicators, precipitated with
trichloroacetic acid, and washed in ethanol (28). After
the addition of 10 ml of Omnifluor (New England
Nuclear Corp., Boston, Mass.) dissolved in toluene,
samples were counted for radioactivity in a Packard
liquid scintillation spectrometer. In assays measuring
RNA or protein synthesis, the precursors were 15,6-
3H]uridine (Schwarz/Mann; 30 Ci/mmol), or L-[G-
3H]serine (New England Nuclear; 2.76 Ci/mmol), re-
spectively. Additions were made 4 h after serum
stimulation, also at a concentration of 2.5 pCi/ml of
medium. Incubation during the assay was at 37°C in an
atmosphere of 95% air-5% CO2.
Some revisions were made in the DNA synthesis
assay to minimize test sample amounts in larger-scale
experiments. In this assay, samples were dissolved in
MEM rather than in PBS, and the solutions were pH
and temperature equilibrated for 30 min in 95% air-5%
CO2 at 37°C. Aliquots (50 ,ul) of these samples were
added directly to each well after the removal of the 48-
h preincubation medium. Even distribution of this
small volume of sample was achieved by placing the
microtiter plate on a Nutator rotating rocker platform
(Clay Adams, Parsippany, N.J.). After 4 h of such
incubation in 95% air-5% CO2 at 37°C, 100 p.l of MEM
with 15% FBS was added to each well; subsequent
steps in the protocol remained unchanged. Preliminary
experiments indicated that this threefold dilution after
a 4-h exposure did not significantly reduce the inhibi-
tory effect compared to the previous assay. Because
less than one-third as much sample was required, we
chose the revised assay for the series of combination
experiments described in Tables 3 and 4.
Purification of B. pertussis TCT. Thirty-hour B.
pertussis cultures in SSM were centrifuged in 200-ml-
capacity bottles at 12,000 x g for 15 min (see Fig. 1).
The supernatant was then filtered twice with 0.2-p.m
Nalgene filter units (Nalgene Labware Div., Nalge/
Sybron Corp., Rochester, N.Y.) to remove any re-
maining bacteria. The pH was adjusted to 7.3 with 6 N
HCl, and 600 ml of sterile culture supernatant was then
placed in a 2-liter-capacity ultrafiltration cell (Amicon
Corp., Lexington, Mass.) with a UM2 membrane
(molecular weight exclusion limit estimated at 1,000).
Subsequent ultrafiltration and column chromatogra-
phy steps were performed at 4°C. After ultrafiltration
at 35 lb/in2 to approximately 80 ml, the retained
material and PBS membrane washings were trans-
ferred to a smaller Amicon stirred cell for further
concentration. Ultrafiltration was continued until the
final volume was 1/100 of the original supernatant. The
pH was readjusted to 7.3 with 1 N HCI, and after
filtration through a 0.2-p.m filter, the concentrated
culture supernatant was frozen in 1-ml aliquots at
-70°C. A Bio-Gel A-1.5 m agarose column (80 by 1.5
cm; Bio-Rad Laboratories, Richmond, Calif.), with a
molecular weight exclusion limit of 1.5 x 106, was
coupled with a 280-nm absorbance monitor (ISCO,
Lincoln, Nebr.) for chromatography. The eluent buffer
was PBS, pH 7.3, supplemented with 0.5 mM MgCl2
and 0.14 mM CaCI2; the flow rate was 10 ml/h, and 1-
ml fractions were collected. After chromatography of
1 ml of concentrated culture supernatant, the low-
molecular-weight peak was collected and placed in a
200-ml-capacity ultrafiltration cell with a UM2 mem-
brane. Salts and other small molecules were removed
by "diafiltration," a process in which ultrafiltrate
leaving the cell is continuously replaced by salt-free
liquid from a pressurized reservoir. This reservoir
solution was 5% glycerol in water, which significantly
reduced binding to the membrane during diafiltration;
it was also used routinely in a 2- to 3-h ultrafiltration
pretreatment of the membranes. After 950 to 1,000 ml
of ultrafiltrate had been collected (approximately 48
h), the sample was concentrated to 3 to 4 ml and
removed from the stirred cell with several 5% glycerol
washes of the membrane. This solution was further
concentrated by lyophilization, and the glycerol was
removed by rechromatography on the same agarose
column, this time preequilibrated for 48 h with deion-
ized water. The major peak, apparently an aggregate
formed in the absence of salts, eluted just after the
void volume. Those fractions were pooled, filter steril-
ized, lyophilized in aliquots, and stored at -20°C in a
desiccator. SSM controls were processed identically
and tested for biological activity after each purification
step.
UV light absorbance of this partially purified B.
pertussis TCT dissolved in PBS was scanned from 190
to 360 nm with a Beckman model 25 recording spectro-
photometer. Absorbance at 204 nm (A204) of TCT was
compared to a standard curve constructed for oxidized
glutathione.
HVPE. Chromatographically purified TCT was ana-
lyzed and further purified by high-voltage paper elec-
trophoresis (HVPE) (15) in a pH 1.9 buffer of formic
acid-acetic acid-water (1:4:50). Samples were spotted
onto Whatman 3MM paper and electrophoresed for 30
min at 3,000 V. Electropherograms were stained with
1% ninhydrin in acetone or with silver nitrate (16). For
preparative HVPE, the TCT sample was dissolved in
2% 2-mercaptoethanol in water and streaked over an 8
to 12-cm horizontal line. Cool air was used to dry the
streak before electrophoresis and to dry the paper
afterward. A vertical guide strip was cut and stained
with ninhydrin as a reference for cutting horizontal
strips corresponding to the electrophoretically sepa-
rated fractions. Material was eluted from the paper by
overnight descending chromatography with pH 1.9
electrophoresis buffer as the eluting solvent. "Blank"
strips were also cut and eluted for buffer controls.
Eluted fractions were lyophilized and then tested on
HTE cells and tracheal rings or analyzed for amino
acids. In experiments with radiolabeled TCT, strips
(10 by 50 mm) were placed into scintillation vials and
soaked with 1 ml of water to elute radioactive compo-
nents from the paper. Samples were incubated over-
night at 37°C with 10 ml of Aquasol-2 (New England
Nuclear), cooled to 4°C, and counted in a Packard
liquid scintillation spectrometer.
Amino acid analysis. HVPE-purified TCT fractions
were hydrolyzed under vacuum in 6 N HCI for 24 h at
110°C. Basic amino acids separated on a column (3.2
by 150 mm) with Aminex A-9 resin (Bio-Rad); neutral
and acidic amino acids were separated on the same
resin in a longer column (3.2 by 250 mm). Performic
acid oxidation (24) before hydrolysis allowed for the
quantitative recovery of cysteine and cystine as cys-
teic acid. Molar ratios were calculated by comparison
to a standard containing 5 nmol of each amino acid.
Oxidized glutathione, for amino acid analysis and for
other experiments, was purchased from Sigma Chemi-
cal Co., St. Louis, Mo.
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Histopathology of tracheal organ cultures. Treated
and control tracheal rings were fixed at various time
points and processed for light microscopy as described
previously (3), except that staining was with toluidine
blue. Sections were examined, and representative
fields were photographed with a Leitz Ortholux II
microscope.
RESULTS
Detection of toxic activity in culture superna-
tant. As a means for evaluating the cytopathic
effect of B. pertussis, we developed a microas-
say to monitor DNA synthesis in serum-stimu-
lated monolayers of mammalian cells. Initially,
B. pertussis broth culture supernatant was as-
sayed to determine whether the organisms re-
leased an inhibitory factor during growth. In
SSM under the growth conditions described
above, cultures harvested 30 h after inoculation
represented late-log-phase organisms according
to time course absorbance readings at 540 nm.
Therefore, the appearance of bacterial products
in the culture supernatant was probably not due
to extensive lysis (as might be expected in the
stationary growth phase). To assay this cell-free
supernatant for inhibitory activity, we first dia-
filtered it extensively with water and a UM2
membrane to remove small molecules that might
compete with radiolabeled thymidine. After ly-
ophilization, the diafiltered culture supernatant
was redissolved in PBS and tested on all three
cell types. When compared with SSM processed
in the same manner, this material caused a dose-
dependent inhibition of DNA synthesis in HTE
cells (Table 1); yet at the same dilutions, BHK
and HEp-2 cells were not significantly affected.
Partial purification of TCT. During the purifi-
cation of TCT from the culture supernatant,
cytotoxicity was monitored as the presence of a
reproducible, statistically significant (P < 0.05
in the Student's t test), dose-dependent inhibi-
TABLE 1. Cell specificity of inhibition by B.
pertussis culture supernatant
% Inhibition of DNA synthesisa
Celltypellblbl:b
1:1b 1l 4b 1:16b
HTE 40.0 26.4 12.8
BHK 7.0 3.2 <0
HEp-2 8.1 <0 1.9
a Based on comparisons between triplicates or qua-
druplicate samples with standard deviations of <10%
of the mean. DNA synthesis was measured as the
incorporation of [3H]thymidine by serum-stimulated
monolayer cell cultures. HTE control values generally
ranged from 3.5 x 104 to 4 x 104 cpm per well in this
microassay.
b Relative dilutions of diafiltered and lyophilized
supernatant test samples and controls; these do not
reflect actual concentrations of culture supernatant.
tion of HTE cell DNA synthesis. Dose-response
curves tended to differ in shape at various stages
of purification, therefore, estimates of activity
and yield from each step were rather qualitative
and are not included here. The rationale for the
procedure outlined in Fig. 1 was an apparent
aggregation of the toxic activity in the absence
of salt. High-molecular-weight contaminants
were eliminated during the first column run with
a PBS eluent. Salts and some small molecules
were then removed by extensive diafiltration,
and other low-molecular-weight contaminants
were discarded in the second (salt-free) column
run. The TCT was detected in the major peak
eluting just after the void volume, indicating an
apparent molecular weight of near 1.5 x 106 for
the aggregate. Other experiments demonstrated
that when the aggregated fraction was redis-
solved in PBS or even in much weaker ionic
solutions, the activity once again appeared in a
low-molecular-weight peak.
The effectiveness of this purification scheme
was initially evaluated by protein analysis on
sodium dodecyl sulfate-polyacrylamide gels of
different porosities. Purification resulted in the
complete disappearance of all protein bands in
the crude culture supernatant (data not shown),
even when examined with highly cross-linked
gels (26). However, we were able to detect the
purified material after HVPE and ninhydrin
staining (Fig. 2). The pattern seen in Fig. 2b was
quite consistent for different preparations. None
of the spots stained with silver nitrate, implying
that the ninhydrin reactivity is probably due to
amino acids rather than free amino sugars.
Further comparison of crude culture superna-
tant with this partially purified TCT is shown in
UV light absorbance spectra (Fig. 3). Since the
purified TCT had a single absorbance peak at
204 nm, we used this wavelength to roughly
quantitate the amounts of material in different
TCT preparations (see below). The concentra-
tions reported here are based on a comparison of
the A2W of TCT and oxidized glutathione (50 ,ug/
ml = 0.85 A204), the major component of this
chromatographically purified fraction (see be-
low). The low A280 not only suggests the absence
of aromatic amino acids in the purified prepara-
tion, but also indicates that the elution profiles in
Fig. 1 are probably misleading for quantitation.
As estimated by A2W comparison with oxi-
dized glutathione, the yield from this purifica-
tion procedure was 0.9 to 1.3 mg from 100 ml of
B. pertussis culture supernatant. Since this ma-
terial has not been completely purified by HVPE
(see below), the estimated concentrations re-
ported in the biological assays do not reflect the
actual concentrations of TCT. However, the
chromatographically purified preparations are
very stable during storage at -20°C compared
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FIG. 1. Chromatographic purification ofB. pertussis tracheal cytotoxin from the culture supernatant. Bio-Gel
A-1.5 m agarose was used for column chromatography; molecular weignt (mw) exclusion limit = 1.5 106.
with the active fraction from further purification
steps; highly purified TCT loses biological activ-
ity within a few weeks. The biological experi-
ments discussed below were therefore per-
formed with only partially purified TCT, and
expressed values for TCT are only for compari-
son among experiments.
Analysis of biological activity. Different puri-
fied preparations consistently generated an HTE
cell dose-response curve like that in Fig. 4. The
correlation coefficient for this regression line as
calculated from four different purified TCT prep-
arations is 0.97. Though this partially purified
TCT produced a concentration-dependent inhi-
bition of DNA synthesis, there was no similar
dose-related inhibition of RNA and protein syn-
theses (Fig. 5). Only at levels of 100 ,ug/ml or
greater did inhibition of RNA synthesis become
statistically significant; protein synthesis re-
mained virtually unaffected even at this high
dose.
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dent's t test. Dose-response comparison of the
a b inhibitory values indicates that the effective
TCT concentration is reduced by approximately
75% as a result of heat treatment.
The most dramatic biological effects of TCT
were seen in longer time course experiments
with organ cultures of hamster tracheal rings
(Fig. 6). When incubated in a TCT concentration
of 50 ,ug/ml, living or sectioned tissue showed no
noticeable changes for the first 60 h. Starting at
60 h, however, extrusion of ciliated cells from
the epithelium was observed in the cultured
rings. By 72 h, ciliary activity had significantly
declined and many more cells had been ex-
pelled. Stained sections showed a reduced num-
ber of ciliated cells; some were extruded and
most appeared less elongated and rounder than
ciliated cells in control rings. At 96 h, ciliary
activity was totally absent, most of the remain-
ing epithelium was nonciliated, and the relative-
I ly few ciliated cells that remained were balloon-
I w shaped and constricted at the apical end. Insharp contrast, control rings at 96 h still had
typically elongated ciliated cells with excellent
ciliary activity. Furthermore, the depth of the
epithelium in TCT-treated tissue was much shal-




FIG. 2. HVPE ofTCT: (a) 30-h culture supernatant
after diafiltration with UM2 membrane and (b) after
purification as in Fig. 1. Origin at arrow; cathode end - -.
of paper at the top; stained with ninhydrin after \
electrophoresis for 30 min at 3,000 V, pH 1.9.
.ll
say have shown that TCT, in contrast to B. 190 210 260 280 360
pertussis endotoxin (6), lost most of its activity Wavelength (nm)
after treatment for 1 h at 1000C (data not shown). FIG. 3. Absorbance of TCT by the UV spectrum.
The difference between the inhibition caused by --- ) Crude culture supernatant (after concentration by
heat-treated and untreated TCT was statistically UM2 ultrafiltration); (-), UV scan of TCT purified as
significant (P < 0.01) in a nondirectional Stu- in Fig. 1.
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TABLE 2. HVPE fraction: incorporation of radioac-
tivity from [3H]glutamic acid for HVPE fractions
% of total radioactivitya






a Percentage of total counts per minute (over back-
ground radiation) in all HVPE fractions. The remain-
ing 25 to 30% of the radioactivity was distributed over
unstained areas of the electropherogram and was only
marginally above background levels.
b Components A and G were not separated in the
absence of 2-mercaptoethanol (Fig. 7).
2.5 5 10 25 50 100 nents in the TCT preparation (Fig. 7 and Table
Concentration (jg/ml) 2). Radioactive fraction A aligned with the major
FIG. 4. Dose-response analysis of TCT: effect of component identified by ninhydrin staining.
the concentration of purified TCT on DNA synthesis However, reduction with 2-mercaptoethanol
in serum-stimulated HTE cells. Each symbol repre- shifted the migration of this ninhydrin-positive
sents a different purification attempt assayed in sepa- spot but did not largely alter the radioactive
rate experiments. All points are calculated from a profile. A ninhydrin-negative spot must there-
comparison of triplicate samples with standard devi- fore exist at the zone marked A and is separated
ations of <10% of the mean. The concentration is from the nonradioactive spot G only under re-
based on comparative peptide A204 (see text), where 50 ducing conditions. Another nonstaining fraction,
,ug/ml = 0.85 A204. labeled C, was also identified by the presence of
radiolabel. A third spot (B) stained weakly with
because nonciliated cells migrated to fill the gaps
left by the extruded ciliated cells. Preliminary
studies with transmission electron microscopy
showed distorted, ballooning mitochondria in
the few ciliated cells remaining after 4 to 5 days
of exposure to TCT; nonciliated cells, however,
had normal ultrastructure.
Tracheal rings exposed to lower doses of TCT
showed the same characteristic pattern of cyto-
pathology, but the time course of events was
somewhat slower. For example, 5 pug ofTCT per
ml required 5 days to completely shut down
ciliary activity as compared with 4 days with 50
,ug/ml. The specific tracheal cell damage mediat-
ed by this toxin from B. pertussis culture super-
natant is comparable to the cytopathology ob-
served in B. pertussis-infected tracheal rings (3).
Electrophoretic purification of TCT. For the
identification of the biologically active fraction
in this partially purified TCT, a final step was
necessary to isolate the chromatographically
distinct components. Ion-exchange resins
proved to be ineffective, so we employed pre-
parative-scale HVPE and were able to elute
fractions by descending chromatography. When
B. pertussis was grown in the presence of
[3H]glutamic acid, analysis of the electrophoret-




















FIG. 5. Effect of TCT on DNA (0), RNA (A), and
protein (O) syntheses by serum-stimulated HTE cells.
Calculations of percent inhibition and concentration





























FIG. 6. Effect of TCT on hamster tracheal rings in organ culture. (a) Control after 96 hours. (b and c) Treated
rings (50 ,ug/ml) after 72 h; ciliated cells appear more rounded, and some are seen extruding from the epithelium.
(d and e) Treated ring after 96 h; occasional balloon-shaped ciliated cells can still be found, but most of the
epithelium is nonciliated, as in (e). Epon 812 sections (0.5 ,um), stained with toluidine blue, all at x569.
ninhydrin and was poorly radiolabeled, though
consistently well above background levels.
Preparative HVPE was also employed to de-
termine whether the biological activity of TCT
could be assigned to any of the radioactive
fractions or to the nonradioactive spot G. In the
HTE cell microassay, values for DNA synthesis
were compared with similarly diluted controls in
which buffer had been eluted from blank strips
of paper. In preliminary experiments, we first
determined a dose at which a 1:1:1:1 combina-
tion of all four fractions caused a statistically
significant inhibition. Fractions were then tested
alone or in other combinations, always with
consistent concentrations of each individual
fraction. Table 3 summarizes the dose-response
analyses compiled from a series of experiments
in which a "positive" combination is defined as
a reproducible, dose-dependent, statistically sig-
nificant inhibition. Fraction B, alone or com-
bined with other fractions, was responsible for
the biological activity of B. pertussis TCT. Fur-
thermore, this purified component also caused
the characteristic TCT cytopathology in organ
VOL. 36, 1982
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FIG. 7. Guide strip cut from HVPE of TCT (a)
dissolved in water, and (b) dissolved in 2% 2-mercap-
toethanol. Note that A and G no longer comigrate
under reducing conditions (see Table 2 for labeling of
spots). Origin at small arrow; cathode end of paper at
the top; stained with ninhydrin after electrophoresis
for 30 min at 3,000 V, pH 1.9.
cultures of tracheal rings, with loss of ciliary
activity and extrusion of ciliated cells.
In the combination experiments with HTE
cells, the presence of both fractions B and G was
more inhibitory to DNA synthesis than was
fraction B alone (Table 4). Since fraction G had
no inhibitory activity by itself, its effect was to
enhance the HTE cytotoxicity of fraction B.
These data suggest that a three- to fourfold
increase in the concentration of TCT would be
required to match the level of inhibition ob-
served after adding component G to component
B. Interestingly, hamster tracheal organ cultures
did not show noticeably increased damage when
component B was supplemented with compo-
nent G. It is difficult to quantitate the effect on
tracheal epithelium, however, since our obser-
vations in that system are based only on the
visual evaluation of ciliary activity and on cell
loss.
Amino acid analysis of HVPE-purified com-
ponents B and G is shown in Table 5. Based on
this comparison with amino acid standards, we
have estimated the composition of toxic fraction
B as glutamic acid (five residues), alanine (five
residues), glycine (two residues), cysteine (two
residues), and diaminopimelic acid (one resi-
due). The identification of diaminopimelic acid
was also confirmed by HVPE. Some amino
sugars consistently survived acid hydrolysis,
and those fractions have been identified as mu-
ramic acid and glucosamine. The peptide portion
alone has an estimated molecular weight of
1,511.5, but the molecular contribution of the
amino sugars or other moieties is still unknown.
The equimolar ratio of glutamic acid, cyste-
ine, and glycine for fraction G corresponds
exactly to the amino acid composition of gluta-
thione (-y-glutamylcysteinylglycine), a compo-
nent of the medium in which the bacteria were
grown. A comparison of the amino acids in
component G with commercially available gluta-
thione is also shown in Table 5. The migration of
component G during HVPE corresponded ex-
actly to the migration of the oxidized form of
glutathione (data not shown), in which two glu-
tathione tripeptides are linked by a disulfide
bond between the cysteine residues. 2-Mercap-
toethanol reduces this molecule to glutathione
tripeptides, which is less basic at this pH and
TABLE 3. Inhibitory activity of HVPE-purified
fractions on HTE cells










B + G ++
C + G
A + B + C +
A + B + C + G ++
a The concentration of fractions, individually or
when combined with others, was the same in all test
samples.
b Summary of results from five separate experi-
ments (involving three different purification attempts).
Symbols: +, reproducible, dose-dependent, statisti-
cally significant (P < 0.05 in non-directional Student's
t test) inhibition of [3H]thymidine incorporation, as
determined by triplicate or quadruplicate samples; -,
no inhibition (P 2 0.05) of DNA synthesis; + +,
enhanced inhibition (Table 4).
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TABLE 4. Effect of fraction G on HTE cell inhibition by fraction B
% Inhibition Dose
HTE cells epsd ta.: Incorporation of of DNA equivalent forHTEc llsx osed o [3H]thymidine' synthesis unfractionated
TCT (,ug/ml)'
Fraction B 25,475 ± 556 27.3 4.4
Buffer elution control 35,047 ± 3,074
Fractions B + G 21,547 ± 1,220 42.1 16.1
Buffer elution control + fraction G 37,204 ± 3,263
a The concentration of component B is constant, but too low to measure by A204; the concentration of
component G = 70 ,ug/ml.
b Mean ± 1 standard deviation from the mean, based on triplicate or quadruplicate samples (representative of
three experiments).
c Corresponding concentration of unfractionated (pre-HVPE) preparation required to cause this level of
inhibition.
migrates more slowly during HVPE (as in Fig.
7). The absence of radiolabel incorporation into
spot G also confirms that its origin must be the
reduced glutathione in SSM; apparently compo-
nent G is oxidized from the reduced form during
broth culture growth. Commercially prepared
oxidized glutathione also substituted for compo-
nent G in combination experiments that demon-
strated enhancement of cytotoxicity by compo-
nent B.
DISCUSSION
The previously described biologically active
components of B. pertussis can be readily distin-
guished from TCT by a number of criteria. For
example, TCT was purified from 30-h log-phase
cultures of B. pertussis BB114 in SSM. In con-
trast, Cowell et al. (4) demonstrated that dermone-
crotic toxin from this same strain grown in identi-
cal medium is undetectable in the culture
supernatant even at 72 h, after bacteria have
entered the stationary growth phase. Second,
most, if not all, of the inhibitory activity of TCT
TABLE 5. Amino acid analysis of HVPE-purified
components B and G
Amino acid compositiona of
component:
B G G
Amino acid (compared (compared (compared
to amino to amino to oxidized
acid acid glutathione)
standards) standards)
Glutamic acid 4.9 1.0 1.0
Alanine 5.1
Glycine 2.1 0.9 1.2
Cysteineb 2.0 0.8 1.0
Diaminopimelic acid 1.0
a Number of residues based on diaminopimelic acid
(for component B) or glutamic acid (for component G)
being defined as 1.0.
b Determined as cysteic acid after oxidation by
performic acid.
was lost when heated at 100°C for 1 h, whereas B.
pertussis endotoxin has been shown to be stable
under those conditions (6). In addition, the mo-
lecular weight of the peptide portion of TCT was
calculated at about 1,500 from amino acid analy-
sis. This differs substantially from molecular
weight estimates of other B. pertussis compo-
nents, such as 95,000 to 130,000 for the fimbrial
hemagglutinin (14, 23), which is believed to be
important in bacterial attachment; 70,000 for
adenylate cyclase (12), which is also released by
log-phase cultures (11); and 77,000 to 108,000 for
pertussigen (see reference 19), a molecule re-
sponsible for a wide range of systemic effects.
Besides the biological and physical discrepan-
cies, an important difference is that none of
these previously characterized molecules has
ever been demonstrated to have a toxic effect on
cells of the respiratory tract. Dermonecrotic
toxin (obtained from J. L. Cowell, Bureau of
Biologics, U.S. Food and Drug Administration),
adenylate cyclase (obtained from E. L. Hewlett,
National Institute of Arthritis, Diabetes, and
Digestive and Kidney Diseases), and pertussi-
gen (obtained from J. J. Munoz, National Insti-
tute of Allergy and Infectious Diseases) have
been tested in this laboratory on HTE cells or
hamster tracheal rings. No cytopathological ef-
fects were observed at concentrations that were
biologically active in other test systems. TCT
appears to be unique in its ability to mimic the
pathogenesis of B. pertussis organisnis on the
respiratory epithelium.
Though the cytopathic effect of TCT on tra-
cheal rings is dramatic, a microassay with se-
rum-stimulated HTE cells has been most useful
in monitoring activity during and after purifica-
tion. Because so little material was required to
inhibit DNA synthesis significantly in these mi-
crotiter-well monolayers, samples could be run
in triplicate or quadruplicate and were thus
amenable to statistical analysis. Given enough
flexibility to assay many samples in a single
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experiment, we were able to develop a purifica-
tion scheme based on the behavior of TCT in an
agarose gel filtration column. When salt was
removed by extensive diafiltration, the low-
molecular-weight activity eluted as a high-mo-
lecular-weight aggregate when chromatographed
with a salt-free eluent. No apparent loss of
inhibitory activity occurred with this aggrega-
tion procedure, and disaggregation took place as
soon as the lyophilized TCT was dissolved in an
ionic solution.
This protocol effectively removed many high-
and low-molecular-weight contaminants, as de-
termined by UV light absorbance and by HVPE.
The absorbance maximum for this partially puri-
fied preparation was 204 nm, which matched the
wavelength for the maximum absorbance of
peptide bonds. By comparing the A204 with that
of known concentrations of oxidized glutathione
(later determined to be the major component in
this preparation), we were able to roughly esti-
mate the concentration of the partially purified
TCT. Standard protein assays, such as A280 or
colormetric reactions, were not applicable since
those estimates vary greatly with the amino acid
compositions of small peptides. The highest
concentration values were obtained with the
A204 comparison, so we chose that method as an
admittedly crude quantitation rather than under-
estimating with one of the other techniques. The
dose-response curves typically showed a high
correlation between concentration and inhibi-
tory activity of different purified preparations,
implying that the A204 estimate of concentration
was at least a reliable means of standardization
between experiments in the same laboratory.
The biological activities of this partially puri-
fied TCT were examined with tracheal cells from
two in vitro systems. Treatment of cultured
HTE cells caused a highly reproducible dose-
dependent inhibition ofDNA synthesis, whereas
RNA synthesis and protein synthesis remained
largely unaffected. The most visible cytopathic
effects were seen with hamster tracheal organ
cultures, where ciliary activity of the respiratory
epithelium was totally lost within 96 h of expo-
sure to TCT. Stained sections of these rings in a
time course study revealed both the abnormal
morphology and the eventual extrusion of ciliat-
ed cells, leaving an almost totally nonciliated
epithelial cell layer. Parallels to virulent B. per-
tussis infection of tracheal organ cultures (3, 20)
are clear. Avirulent strains do not attach to or
damage ciliated cells (21), though it is not known
whether such strains produce TCT. Even ifTCT
is released, however, the inability of these aviru-
lent organisms to colonize cells and establish a
respiratory tract infection precludes the possibil-
ity of delivering the toxic molecule to its target
cell.
Chromatographically purified TCT was fur-
ther fractionated on the basis of radioactivity
incorporation, with [3H]glutamic acid as a pre-
cursor in the B. pertussis culture medium. By
running preparative-scale HVPE under reducing
conditions, we purified fractions corresponding
to all three radioactive components (A, B, and
C), as well as the major ninhydrin-positive (but
nonradioactive) fraction (G). Amino acid analy-
sis and comparative HVPE identified fraction G
as oxidized glutathione, a component apparently
originating from the growth medium. When frac-
tion G and the other individual fractions were
tested on HTE cells in various combinations, it
was clear that component B was the toxic com-
ponent of B. pertussis TCT. This was confirmed
when hamster tracheal organ cultures exposed
to component B showed typical TCT pathogene-
sis.
Amino acid analysis of HVPE-purified com-
ponent B revealed a composition of glutamic
acid (five residues), alanine (five residues), gly-
cine (two residues), cysteine (two residues), and
diaminopimelic acid (one residue). Including
only this peptide portion, the molecular weight
of component B is 1,511.5. Muramic acid and
glucosamine were also detected, but the correct
molar ratios are still unknown due to a partial
loss of these amino sugars during acid hydroly-
sis. The presence of both diaminopimelic acid
and muramic acid strongly implies that at least
part of this molecule originates from the B.
pertussis peptidoglycan (5). The release of solu-
ble peptidoglycan fragments from exponentially
growing gram-negative organisms has precedent
in studies with Neisseria gonorrhoeae (22).
However, the large numbers of alanine and
glutamic acid residues suggest that component B
consists of more than a peptidoglycan subunit;
in fact, glycine and cysteine have never been
demonstrated in the peptidoglycan of gram-neg-
ative bacteria. How these additional amino acids
are linked to or associated with the peptidogly-
can fragment remains unknown. They are not
simply the result of contamination by glutathi-
one, as indicated by the absence of a glutathione
spot after repeated HVPE of purified component
B.
The low yield of component B, its weak
ninhydrin staining, and its low radiolabeling
efficiency suggest that it is present in only very
small amounts compared with oxidized glutathi-
one. The inhibitory concentrations of TCT esti-
mated in Figs. 4 through 6 are based primarily on
the amount of oxidized glutathione and therefore
are far in excess of the actual toxic levels of
component B. Based on yield (determined from
amino acid analysis) after HVPE, we estimate
that TCT may be as much as 15 times more
"potent" than estimated in those experiments.
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Although fraction B is certainly the toxic
fraction, glutathione may be more than a fortu-
itous contaminant from the culture medium.
Component B seems to be tightly bound to
oxidized glutathione, with the two consistently
behaving like a single molecule on gel filtration
and ion-exchange columns; only a strong electri-
cal field at a low pH separates the two compo-
nents. Furthermore, oxidized glutathione en-
hanced the effect of component B on HTE cells
to a level of inhibition corresponding to a three-
to fourfold increase in TCT concentration. If
oxidized glutathione indeed participates in the
toxicity of TCT in vitro, might it also assume a
role during B. pertussis infection in vivo?
Glutathione is a major constituent inside
mammalian cells, although B. pertussis infection
takes place extracellularly. However, recent
studies with mice (9) as well as with lymphoid
cells (10) and fibroblasts (1) have shown that
cells normally translocate glutathione across the
plasma membrane. Once outside the cell, gluta-
thione may be oxidized by a specific membrane-
bound glutathione oxidase (27) or perhaps by B.
pertussis, which probably oxidized glutathione
during broth culture growth. Thus, the cells
lining the respiratory tract provide an extracellu-
lar source of oxidized glutathione that may asso-
ciate with component B released from the organ-
isms. The enhancement of component B
cytotoxicity in the presence of oxidized glutathi-
one was not visualized in tracheal organ cul-
tures, but those cultures may be inappropriate
for the observation of a glutathione effect. In
addition to difficulties in quantitative evaluation,
leakage of glutathione from the cells damaged by
trachea slicing may mask the effect of exoge-
nously supplied oxidized glutathione. HTE cells
probably serve as a cleaner model to analyze the
relationship of oxidized glutathione to toxic
component B (though glutathione may simply
increase the stability of component B in solution
and during storage).
The relationship of DNA synthesis inhibition
in HTE cells to the cytopathology seen in tra-
cheal ring cultures is not yet understood. How-
ever, the effect on DNA synthesis occurred
quite early (within 30 h after exposure) com-
pared with the first visible effects on ciliated
cells, which required at least twice as much
time. The DNA synthesis inhibition of HTE
cells may therefore reflect an early stage in the
overall cytopathology that is seen later in organ
cultures of tracheal rings. It may also indicate a
toxic activity that cannot be measured with
tracheal organ cultures-an effect on regenera-
tion. Once damaged, the respiratory epithelium
does not repair itself in vitro; in vivo, damaged
or extruded cells are typically replaced by an
underlying layer of basal cells, which divide and
differentiate to the required specialized cell type
(17). It therefore seems possible that B. pertussis
TCT not only destroys the ciliated cell popula-
tion but also partially or completely inhibits the
normal replacement of epithelial cells.
The small size of TCT, and therefore its loss
during many protein purification techniques, can
easily explain why it has not been detected
previously. More importantly, the activity may
have been overlooked because of its specificity;
even other cultured cells, such as HEp-2 and
BHK, which allow the attachment of B. pertus-
sis, were unaffected in terms of DNA synthesis
inhibition. The most significant factor in the
discovery and purification of this toxin was the
availability of an appropriate cellular model of
the respiratory tract. Animal models will also be
an important subsequent step in understanding
the role of B. pertussis TCT in vivo and in
determining how well the pathogenesis corre-
lates with in vitro systems.
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